Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 240.00
-0.80 (-0.33%)
Nov 12, 2026, 5:24 PM IST
Matricelf Market Cap
Matricelf has a market cap or net worth of 79.42 million as of November 12, 2026. It is the 34,927th most valuable company in the world and the 389th biggest in Israel. Its market cap has decreased by 32.48% in one year.
Market Cap
79.42M
Enterprise Value
68.73M
Revenue
n/a
Global Rank
Country Rank
#389 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 79.42M, an increase of 28.11%. That is a compound annual growth rate of 4.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 80.48M | -47.03% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 179.89M |
| Clal Biotechnology Industries | 33.72M |
| Purple Biotech | 32.42M |
| BioLineRx | 29.87M |
| BioLight Life Sciences | 27.15M |
| Evogene | 17.38M |
| XTL Biopharmaceuticals | 17.22M |
| Can-Fite BioPharma | 15.85M |